U.S. Markets closed

Outset Medical, Inc. (OM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
55.50+1.65 (+3.06%)
At close: 4:00PM EDT

55.50 0.00 (0.00%)
After hours: 5:07PM EDT

Outset Medical, Inc.

3052 Orchard Drive
San Jose, CA 95134
United States
669 231 8200

IndustryMedical Devices
Full Time Employees313

Key Executives

NameTitlePayExercisedYear Born
Ms. Leslie L. TriggPres, CEO & Director690.09kN/A1971
Ms. Rebecca ChambersChief Financial Officer485.79kN/A1978
Mr. Martin VazquezChief Operating Officer591.49kN/A1970
Mr. John L. BrottemGen. Counsel & Sec.N/AN/A1974
Ms. Stacey PorterVice Pres of People OperationsN/AN/AN/A
Dr. Michael Aragon M.D.Chief Medical OfficerN/AN/AN/A
Ms. Tonya SafferHead of Gov. Affairs & Market AccessN/AN/AN/A
Mr. Steve WilliamsonChief Commercial OfficerN/AN/A1973
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Corporate Governance

Outset Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.